您的购物车当前为空
(±)10(11)-DiHDPA is produced from cytochrome P450 epoxygenase action on docosahexaenoic acid . It has been shown to inhibit VEGF-induced angiogenesis in mice and may have additional anti-inflammatory and anti-tumor effects.
(±)10(11)-DiHDPA is produced from cytochrome P450 epoxygenase action on docosahexaenoic acid . It has been shown to inhibit VEGF-induced angiogenesis in mice and may have additional anti-inflammatory and anti-tumor effects.

| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 50 μg | ¥ 2,130 | 35日内发货 | |
| 100 μg | ¥ 3,660 | 35日内发货 | |
| 500 μg | ¥ 14,300 | 35日内发货 | |
| 1 mg | ¥ 23,600 | 35日内发货 |
TargetMol的所有产品仅用作科学研究或药证申报,不能被用于人体,我们不向个人提供产品和服务。请您遵守承诺用途,不得违反法律法规规定用于任何其他用途。
| 产品描述 | (±)10(11)-DiHDPA is produced from cytochrome P450 epoxygenase action on docosahexaenoic acid . It has been shown to inhibit VEGF-induced angiogenesis in mice and may have additional anti-inflammatory and anti-tumor effects. |
| 分子量 | 362.51 |
| 分子式 | C22H34O4 |
| CAS No. | 1345275-22-0 |
| Smiles | CC\C=C/C\C=C/C\C=C/CC(O)C(O)C\C=C/C\C=C/CCC(O)=O |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. 实际储存温度请以COA为准 |
| 溶解度信息 | DMSO: 50 mg/mL (137.93 mM), Sonication is recommended. PBS (pH 7.2): 0.25 mg/mL (0.69 mM), Sonication is recommended. Ethanol: 50 mg/mL (137.93 mM), Sonication is recommended. DMF: 50 mg/mL (137.93 mM), Sonication is recommended. |
对于不同动物的给药剂量换算,您也可以参考 更多